The influence of therapists’ first-hand experience with psychedelics on psychedelic-assisted psychotherapy research and therapist training
Nielson, E. M., & Guss, J. | Journal of Psychedelic Studies | 22 August 2018
Psilocybin and Mental Health–Don’t Lose Control
Barnby, J. M., & Mehta, M. A. | Frontiers in Psychiatry | 3 July 2018
High dose psilocybin is associated with positive subjective effects in healthy volunteers
Nicholas, C. R., Henriquez, K. M., Gassman, M. C., Cooper, K. M., Muller, D., Hetzel, S., ... & Hutson, P. R. | Journal of Psychopharmacology | 27 June 2018
Mental health of a self-selected sample of psychedelic users and self-medication practices with psychedelics
Mason, N. L., & Kuypers, K. P. | Journal of Psychedelic Studies | 25 June 2018
Psychedelic therapy for smoking cessation: Qualitative analysis of participant accounts
Noorani, T., Garcia-Romeu, A., Swift, T. C., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 25 June 2018
Psychedelics and hypnosis: Commonalities and therapeutic implications
Lemercier, C. E., & Terhune, D. B. | Journal of Psychopharmacology | 25 June 2018
Effects of psilocybin therapy on personality structure
Erritzoe, D., Roseman, L., Nour, M. M., MacLean, K., Kaelen, M., Nutt, D. J., & Carhart‐Harris, R. L. | Acta Psychiatrica Scandinavica | 19 June 2018
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Palhano-Fontes, F., Barreto, D., Onias, H., Andrade, K. C., Novaes, M. M., Pessoa, J. A., ... & Tófoli, L. F. | Psychological medicine | 15 June 2018
Psychedelics Promote Structural and Functional Neural Plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., ... & Duim, W. C. | Cell reports | 12 June 2018
The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act
Johnson, M. W., Griffiths, R. R., Hendricks, P. S., & Henningfield, J. E. | Neuropharmacology | 5 June 2018
A Survey of American Psychiatrists’ Attitudes Toward Classic Hallucinogens
Barnett, B. S., Siu, W. O., & Pope Jr, H. G. | The Journal of nervous and mental disease | 1 June 2018
Psychedelic therapy as a complementary treatment approach for alcohol use disorders
Eischens, P., & Atherton, W. L. | Journal of Psychedelic Studies | 30 May 2018
3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in service personnel
Cipriani, A., & Cowen, P. J. | Lancet Psychiatry | 1 May 2018
Integrating Psychedelic Medicines and Psychiatry: Theory and Methods of a Model Clinic
Sloshower, J. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018
Placebo Problems: Boundary Work in the Psychedelic Science Renaissance
Hendy, K. | Plant Medicines, Healing and Psychedelic Science: Cultural Perspectives | 29 April 2018
Effects of N, N-Dimethyltryptamine on Rat Behaviors Relevant to Anxiety and Depression
Cameron, L. P., Benson, C. J., Dunlap, L. E., & Olson, D. E. | ACS chemical neuroscience | 24 April 2018
Hypothesis: The Psychedelic Ayahuasca Heals Traumatic Memories via a Sigma 1 Receptor-Mediated Epigenetic-Mnemonic Process
Inserra, A. | Frontiers in pharmacology | 5 April 2018
Changes in Withdrawal and Craving Scores in Participants Undergoing Opioid Detoxification Utilizing Ibogaine
Malcolm, B. J., Polanco, M., & Barsuglia, J. P. | Journal of psychoactive drugs | 2 April 2018
Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression
Carrillo, F., Sigman, M., Slezak, D. F., Ashton, P., Fitzgerald, L., Stroud, J., ... & Carhart-Harris, R. L. | Journal of affective disorders | 30 March 2018
Four weekly ayahuasca sessions lead to increases in “acceptance” capacities: a comparison study with a standard 8-week mindfulness training program
Soler, J., Elices, M., Dominguez-Clave, E., Pascual, J. C., Feilding, A., Navarro-Gil, M., ... & Riba, J. | Frontiers in Pharmacology | 20 March 2018
Role of the 5-HT2A receptor in self- and other-initiated social interaction in LSD-induced states – a pharmacological fMRI study
Preller, K. H., Schilbach, L., Pokorny, T., Flemming, J., Seifritz, E., & Vollenweider, F. X. | Journal of Neuroscience | 19 March 2018
Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives
Martinotti, G., Santacroce, R., Pettorruso, M., Montemitro, C., Spano, M. C., Lorusso, M., ... & Lerner, A. G. | Brain sciences | 16 March 2018
Repeated intranasal ketamine for treatment-resistant depression – the way to go? Results from a pilot randomised controlled trial
Gálvez, V., Li, A., Huggins, C., Glue, P., Martin, D., Somogyi, A. A., ... & Loo, C. K. | Journal of Psychopharmacology | 15 March 2018
Serotonergic Psychedelics: Experimental Approaches for Assessing Mechanisms of Action
Canal, C. E. | Handbook of Experimental Pharmacology | 13 March 2018
MDMA-assisted psychotherapy for PTSD: Are memory reconsolidation and fear extinction underlying mechanisms?
Feduccia, A. A., & Mithoefer, M. C. | Progress in neuro-psychopharmacology and biological psychiatry | 7 March 2018